Special Products Limited – Trademark Portfolio
Entity Type: 98
Special Products Limited holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EPISTATUS.
Unit 16, Trade City, Avro Way,
Brooklands Business Park Weybridge, Surrey KT13 0YF
Showing of trademarks Trademarks
Trademark Classifications
Special Products Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Special Products Limited have?
Special Products Limited has 19 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Special Products Limited file in?
Special Products Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Special Products Limited's most well-known trademarks?
Special Products Limited's registered trademark portfolio includes well-known marks such as EPISTATUS. These are among 1 currently registered trademark in the portfolio.
What is Special Products Limited's trademark registration success rate?
Special Products Limited has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.